Previous close | 105.79 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 2,873 |
Market cap | 658.579M |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | 0.22 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Emerson's (NYSE: EMR) Test and Measurement business, formerly NI, today announced its premier NI Connect event will showcase the latest in intelligent NI test and measurement technologies driving innovation and enhancing business performance. The event for test and measurement customers and business and technology leaders runs May 21-22 in Austin, Texas.
Emerson (NYSE: EMR) will report its second quarter results prior to market open on Wednesday, May 8, 2024. Emerson senior management will discuss the results during an investor conference call that same day, beginning at 9 a.m. Eastern Time, 8 a.m. Central Time.
Global automation technology and software leader Emerson (NYSE: EMR) today introduced DeltaV™ Workflow Management, a next-generation software designed for life sciences companies in early-stage development. The new software continues Emerson's expansion of capabilities of the evolving DeltaV automation platform to offer more scalable options to suit the needs of smaller life sciences innovators. For companies with limited IT infrastructure, DeltaV Workflow Management provides a cloud-based, soft